Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Vito Annese

Showing results (1-10 of 182) with videos related to

Pageof 19
Sort By:
Pharmacological Research|May 29, 2020
Genetics and epigenetics of IBDVito Annese
Saudi Journal of Medicine & Medical Sciences|May 14, 2019
A Review of Extraintestinal Manifestations and Complications of Inflammatory Bowel DiseaseVito Annese
Current Drug Targets|April 7, 2011
Genetics and ulcerative colitis: what are the clinical implications?Anna Latiano, Vito Annese
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|August 21, 2014
Use of biosimilars in inflammatory bowel disease: Statements of the Italian Group for Inflammatory Bowel DiseaseVito Annese, Maurizio Vecchi,
Diagnostics (Basel, Switzerland)|September 9, 2023
Precision Medicine in Inflammatory Bowel DiseaseVito Annese, Monica Annese
World Journal of Gastroenterology|September 29, 2006
Non-surgical treatment of esophageal achalasiaVito Annese, Gabrio Bassotti
World Journal of Gastroenterology|January 28, 2017
Biosimilars in inflammatory bowel disease: A review of post-marketing experienceSimona Deiana, Tommaso Gabbani, Vito Annese
Drug Design, Development and Therapy|June 28, 2017
CT-P13: design, development, and place in therapyTommaso Gabbani, Simona Deiana, Vito Annese
Expert Opinion on Emerging Drugs|March 4, 2015
Emerging drug for diarrhea predominant irritable bowel syndromeSimona Deiana, Tommaso Gabbani, Siro Bagnoli, et al.
PPAR Research|September 22, 2012
PPARγ in Inflammatory Bowel DiseaseVito Annese, Francesca Rogai, Alessia Settesoldi, et al.
Pageof 19

Showing results (1-10 of 182) with videos related to

Sort By:
Pageof 19
Pharmacological Research|May 29, 2020
Genetics and epigenetics of IBDVito Annese
Saudi Journal of Medicine & Medical Sciences|May 14, 2019
A Review of Extraintestinal Manifestations and Complications of Inflammatory Bowel DiseaseVito Annese
Current Drug Targets|April 7, 2011
Genetics and ulcerative colitis: what are the clinical implications?Anna Latiano, Vito Annese
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|August 21, 2014
Use of biosimilars in inflammatory bowel disease: Statements of the Italian Group for Inflammatory Bowel DiseaseVito Annese, Maurizio Vecchi,
Diagnostics (Basel, Switzerland)|September 9, 2023
Precision Medicine in Inflammatory Bowel DiseaseVito Annese, Monica Annese
World Journal of Gastroenterology|September 29, 2006
Non-surgical treatment of esophageal achalasiaVito Annese, Gabrio Bassotti
World Journal of Gastroenterology|January 28, 2017
Biosimilars in inflammatory bowel disease: A review of post-marketing experienceSimona Deiana, Tommaso Gabbani, Vito Annese
Drug Design, Development and Therapy|June 28, 2017
CT-P13: design, development, and place in therapyTommaso Gabbani, Simona Deiana, Vito Annese
Expert Opinion on Emerging Drugs|March 4, 2015
Emerging drug for diarrhea predominant irritable bowel syndromeSimona Deiana, Tommaso Gabbani, Siro Bagnoli, et al.
PPAR Research|September 22, 2012
PPARγ in Inflammatory Bowel DiseaseVito Annese, Francesca Rogai, Alessia Settesoldi, et al.
Pageof 19